Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,723 Jan 1 – Oct 26, 2026
- Disclosed funding
- $340.2B 3673 disclosed amounts
- Median round
- $14.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| SP Develops next-generation peptide radioligand therapies for cancer | $18M | Series A | Biotech | United States | Investors | |
| PS ProSomnus Sleep TechnologiesCompany profile Provides non-CPAP alternative for Obstructive Sleep Apnea treatment Provides non-CPAP alternative for Obstructive Sleep Apnea treatment | $38M | StrategicUndisclosed | Healthtech | United States | Investors | |
| O OnshoreCompany profile Builds AI-powered platform to help businesses claim and defend tax incentives like R&D credits with automation and expert review Builds AI-powered platform to help businesses claim and defend tax incentives like R&D credits with automation and expert review | $31M | Series B | Fintech | United States | Investors | |
| SM Synchrony MedicalCompany profile Provides at-home airway clearance therapy for chronic respiratory disease Provides at-home airway clearance therapy for chronic respiratory disease | $5M | Seed | Healthtech | United States | Investors | |
| V Provides infrastructure platform powering America's modern savings economy | $385M | Series ESeries C+ | Fintech | United States | Investors | |
| CS Cogent SecurityCompany profile Builds autonomous AI agents to automate vulnerability remediation for security teams Builds autonomous AI agents to automate vulnerability remediation for security teams | $42M | Series A | Cybersecurity | United States | Investors | |
| EM Develops image-enabled technologies for complex coronary interventions | Undisclosed | Series CSeries C+ | Healthtech | United States | Investors Undisclosed | |
Pharmacelera uses quantum-mechanics methods and AI in drug discovery. | €6M | Growth | Biotech | Spain | Investors | |
| N Builds a commission-free, peer-to-peer sports prediction market platform | $75M | Series B | Consumer | United States | Investors | |
| SB Sift BiosciencesCompany profile Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases | $3.7M | Pre-SeedPre-seed | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
111rounds21led - 3General Catalyst
Matiks, Provision Labs, Tractian
102rounds13led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds8led - 5Sequoia Capital
Nevis, Warhound, Whop
72rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →